Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Journal: Nature Communications

Published: 2020-08-27

DOI: 10.1038/s41467-020-17645-z

Affiliations: 8

Authors: 19

Go to article
Institutions Share
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.97
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA) 0.03

Return